ConductScience.org, home

Trial · NCT01229228

Participant flow15

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDNaproxen Test (Lower Dose)51
Overall StudySTARTEDNaproxen Test (Upper Dose)51
Overall StudySTARTEDNaprosyn 250 mg50
Overall StudySTARTEDNaprosyn 500 mg51
Overall StudySTARTEDPlacebo51
Overall StudyCOMPLETEDNaproxen Test (Lower Dose)50
Overall StudyCOMPLETEDNaproxen Test (Upper Dose)51
Overall StudyCOMPLETEDNaprosyn 250 mg49
Overall StudyCOMPLETEDNaprosyn 500 mg51
Overall StudyCOMPLETEDPlacebo50
Overall StudyNOT COMPLETEDNaproxen Test (Lower Dose)1
Overall StudyNOT COMPLETEDNaproxen Test (Upper Dose)0
Overall StudyNOT COMPLETEDNaprosyn 250 mg1
Overall StudyNOT COMPLETEDNaprosyn 500 mg0
Overall StudyNOT COMPLETEDPlacebo1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01229228/flow